Analystreport

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $22.00 price target on the stock.

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com